DK1109538T3 - Antiinflammatoriske farmaceutiske formuleringer - Google Patents

Antiinflammatoriske farmaceutiske formuleringer

Info

Publication number
DK1109538T3
DK1109538T3 DK99944682T DK99944682T DK1109538T3 DK 1109538 T3 DK1109538 T3 DK 1109538T3 DK 99944682 T DK99944682 T DK 99944682T DK 99944682 T DK99944682 T DK 99944682T DK 1109538 T3 DK1109538 T3 DK 1109538T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulations
inflammatory pharmaceutical
mixture
inflammatory
nsaid
Prior art date
Application number
DK99944682T
Other languages
Danish (da)
English (en)
Inventor
Austen John Woolfe
John Woolfe Austin
Gordon Mcintyre
Nitin Vadilal Sheth
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of DK1109538T3 publication Critical patent/DK1109538T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99944682T 1998-09-10 1999-09-10 Antiinflammatoriske farmaceutiske formuleringer DK1109538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819685.0A GB9819685D0 (en) 1998-09-10 1998-09-10 Anti-inflammatory pharmaceutical formulations
PCT/GB1999/002831 WO2000015200A1 (en) 1998-09-10 1999-09-10 Anti-inflammatory pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1109538T3 true DK1109538T3 (da) 2003-08-25

Family

ID=10838600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944682T DK1109538T3 (da) 1998-09-10 1999-09-10 Antiinflammatoriske farmaceutiske formuleringer

Country Status (9)

Country Link
EP (1) EP1109538B1 (de)
AT (1) ATE238775T1 (de)
AU (1) AU5750799A (de)
DE (1) DE69907481T2 (de)
DK (1) DK1109538T3 (de)
ES (1) ES2198956T3 (de)
GB (1) GB9819685D0 (de)
PT (1) PT1109538E (de)
WO (1) WO2000015200A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6183779B1 (en) 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
EP1216030A1 (de) * 1999-10-01 2002-06-26 Norton Healthcare Limited Entzündungshemmende pharmazeutische formulierungen
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016895A1 (en) * 1990-05-03 1991-11-14 G.D. Searle & Co. Pharmaceutical composition
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物

Also Published As

Publication number Publication date
DE69907481D1 (de) 2003-06-05
GB9819685D0 (en) 1998-11-04
EP1109538A1 (de) 2001-06-27
AU5750799A (en) 2000-04-03
WO2000015200A1 (en) 2000-03-23
ES2198956T3 (es) 2004-02-01
PT1109538E (pt) 2003-09-30
ATE238775T1 (de) 2003-05-15
EP1109538B1 (de) 2003-05-02
DE69907481T2 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
DE69819351D1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
CY1105170T1 (el) Συνταγοποιηση απο του στοματος δοσολογιας αστραπιαιας - τηξης
AP1954A (en) Controlled release compositions comprising nimesulide.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
DK1276467T3 (da) Formuleringer og tabletter til forhalet frigivelse af guaifenesin
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
SE9804314D0 (sv) New pharmaceutical formulation
CY1106072T1 (el) Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
NO20004823L (no) Nye galeniske formuleringer av meloksicam for oral administrering
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
ES2160145T3 (es) Composicion farmaceutica para la administracion oral de flavonoides.
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
SE9700885D0 (sv) New pharmaceutical formulation
ATE304844T1 (de) Entzündungshemmende pharmazeutische formulierungen
DK1109538T3 (da) Antiinflammatoriske farmaceutiske formuleringer
PT1249231E (pt) Formulacoes farmaceuticas contendo substancias activas anti-inflamatorias e sua utilizacao
MXPA02012344A (es) Composiciones y anti-inflamatorias que contienen inhibidores cox-2.
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina
MY145885A (en) Controlled release formulations for oral administration